University rampage sparks new protests across India

1 / 2
Students and supporters hold placards as they shout slogans during a protest against an attack on the students and teachers at the Jawaharlal Nehru University (JNU) campus in New Delhi a day before, at Osmania University campus in Hyderabad on January 6, 2020. (AFP)
2 / 2
Demonstrators attend a protest against attacks on the students of New Delhi's Jawaharlal Nehru University (JNU), outside the Gateway of India monument in Mumbai, India, January 6, 2020. (REUTERS)
Short Url
Updated 07 January 2020

University rampage sparks new protests across India

  • Nobel economy prize winner Abhijeet Banerjee, a former JNU student, said the attacks had "echoes of the years when Germany was moving towards Nazi rule"

NEW DELHI: New Delhi police are investigating how masked men burst into a leading university and attacked student protesters with sticks and rods, an officer said on Monday, the latest incident to ignite criticism of India’s ruling Hindu nationalists.
Sunday’s attack at a university long seen as a bastion of left-wing politics comes as students nationwide lead a campaign against a citizenship law introduced last month by Prime Minister Narendra Modi that is seen as discriminating against Muslims.
“Social media and CCTV footage will be part of the investigation,” said police official Devendra Arya, adding the violence at the university had prompted police to start a case.
Students and some faculty of the Jawaharlal Nehru University have blamed the incident that injured at least 30 people on a students’ union tied to Modi’s Bharatiya Janata Party that has increasingly picked on the institution.
Students put out pictures of mobs entering university residential halls, their faces covered with cloth, carrying sticks and even sledgehammers. Some shouted slogans, threatening death for traitors.
Students said police had failed to act, leaving them at the mercy of the mob.
Delhi police said they had launched an investigation.
More than 30 people injured were admitted to the All-India Institute of Medical Science in the capital, a hospital official said, most of them with lacerations, cuts and bruises.
The protests have persisted, with more demonstrations planned across India on Monday, prompted by the university attack.
The Akhil Bharatiya Vidyarthi Parishad, the students’ wing of the BJP, denied accusations that it was behind the attack, which it blamed instead on rival leftist unions.
Authorities faced criticism for failing to rein in the violence on a campus viewed a center of resistance to Modi’s policies, including the abolition last year of special status for Muslim-majority Kashmir.
Amit Thorat, who teaches economics at JNU, said he called the police a little after 7 p.m. on Sunday but they didn’t come until an hour later. Nearly a dozen students Reuters spoke to said police watched as the mob rampaged inside the campus.
“I...hang my head in shame after witnessing video clips of goons merrily entering JNU campus, creating mayhem and grievously injuring innocent students, damaging public property and then exiting the campus,” Rahul Mehra, a lawyer for the Delhi police, said on Twitter.

MEDICAL WORKERS TARGETED
Even medical teams trying to help the injured were attacked, said Harjit Bhatti, former president of the resident doctors’ association at the All India Institute of Medical Sciences.
“Our team of doctors, nurses & medical volunteers who reached JNU to give first aid to injured students & teachers, was attacked by hundreds of goons,” he said in a tweet. “Mob manhandled doctors, nurses & threatened them. Our ambulance’s glass & windows broken, this is totally inhuman & insane.”
Critics say the Modi administration is trying to crush dissent as it advances a Hindu-first agenda that undermines India’s foundations as a secular democracy.
The citizenship law lays out a path for Indian nationality for minorities from six religious groups in neighboring countries but excludes Muslims.
The government says the law is meant to tackle the grievances of minorities, such as Christians, Hindus and Sikhs, who face persecution in Afghanistan, Bangladesh and Pakistan.


US to pay over $1bn for 100m doses of J&J’s potential COVID-19 vaccine

Updated 05 August 2020

US to pay over $1bn for 100m doses of J&J’s potential COVID-19 vaccine

  • The latest contract equates to roughly $10 per vaccine dose produced by J&J
  • This is J&J’s first deal to supply its investigational vaccine to a country

WASHINGTON: The United States government will pay Johnson & Johnson over $1 billion for 100 million doses of its potential coronavirus vaccine, its latest such arrangement as the race to tame the pandemic intensifies, the drugmaker said on Wednesday.
It said it would deliver the vaccine to the Biomedical Advanced Research and Development Authority (BARDA) on a not-for-profit basis to be used after approval or emergency use authorization by the US Food and Drug Administration (FDA).
J&J has already received $1 billion in funding from the US government — BARDA agreed in March to provide that money for the company to build manufacturing capacity for more than 1 billion doses of the experimental vaccine.
The latest contract equates to roughly $10 per vaccine dose produced by J&J. Including the first $1 billion deal with the USgovernment, the price would be slightly higher than the $19.50 per dose that the United States is paying for the vaccine being developed by Pfizer Inc. and German biotech BioNTech SE.
The US government may also purchase an additional 200 million doses under a subsequent agreement. J&J did not disclose that deal’s value.
J&J plans to study a one- or two-dose regimen of the vaccine in parallel later this year. A single-shot regimen could allow more people to be vaccinated with the same number of doses and would sidestep issues around getting people to come back for their second dose.
This is J&J’s first deal to supply its investigational vaccine to a country. Talks are underway with the European Union, but no deal has yet been reached.
J&J’s investigational vaccine is currently being tested on healthy volunteers in the United States and Belgium in an early-stage study.
There are currently no approved vaccines for COVID-19. More than 20 are in clinical trials.